United States Patent and Trademark Office, Patent Assignment 11921/920:
Assignment Of Assignors Interest
Assignors
Assignees
Tojo, Shinichiro
Paperwork Executed May 8, 2001
Nita, Masahiro
Paperwork Executed May 8, 2001
Nishimura, Takeshi
Paperwork Executed April 27, 2001
Shan, Bei
Paperwork Executed May 2, 2001
Recorded
June 22, 2001
Sumitomo Pharmaceuticals Company, Ltd.
Tularik, Inc.
Officially Listed As "Tularik Inc."
Tularik, Inc.
South San Francisco, CA 94080
Patents
Correspondents
Therapeutic agent for hyperlipidemia
X0 Patent Application No. 09782535 , Filed February 13, 2001
A1 Application Publication No. 20020119958, Issued August 29, 2002
John Palmer Fishwick, Jr.
Leydig Voit & Mayer, Ltd.
2 Prudential Plaza
Ste 4900
Chicago, IL 606016780
Phone: +1 318 221 1600
Fax: +1 318 425 1256
E-Mail: john.fishwick@fishwickandassociates.com
Updated October 24, 2002
View this assignment via USPTO Assignments on the Web
Statistics
This assignment has been viewed 3 times.
Information Facts
https://www.plainsite.org/patents/assignment.html?id=2111303
Primary Sources
Government agencies: SEC/EDGAR, federal and state courts, USPTO, IRS, and others
AI text generation None
AI document summarization None
AI-augmented search None
AI-generated images None
AI chat or Q&A interface Linkable via MCP
Third party AI contribution in government documents Possible
Document content is reproduced directly from government sources. Some filings in our database may themselves contain AI-generated content submitted by third parties to government agencies.